INmune Bio, Inc.INMBNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
0.00%
↓ 100% below average
Average (36q)
26.78%
Historical baseline
Range
High:1064.29%
Low:-100.00%
Volatility
4348.0%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | -50.00% |
| Q4 2023 | -34.88% |
| Q3 2023 | -6.52% |
| Q2 2023 | 21.05% |
| Q1 2023 | -60.82% |
| Q4 2022 | -1.02% |
| Q3 2022 | 512.50% |
| Q2 2022 | -90.18% |
| Q1 2022 | 0.00% |
| Q4 2021 | 1064.29% |
| Q3 2021 | 0.00% |
| Q2 2021 | -100.00% |
| Q1 2021 | -63.64% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |